Group Number Group Name Group Abbreviation Cell Type Cisplatin Treatment (mM) Number of Samples Per Group Total Number of Replicate Injections Per Group
1 A2780 C1S Sensitive 0 6 12
2 A2780CP C1R00 Resistant 0 6 12
3 A2780CP-10 C1R10 Resistant 10 6 12
4 A2780CP-20 C1R20 Resistant 20 6 12
5 2008 C2S Sensitive 0 6 12
6 2008C13 C2R00 Resistant 0 6 12
7 2008C13-10 C2R10 Resistant 10 6 12
8 2008C13-20 C2R20 Resistant 20 6 12
Table 1: Experimental Design.